JPMorgan Names Four Pharma Picks, Torrent Leads Upside

JPMorgan looked at several drug companies and picked four it rates positively.

Torrent Pharma has the biggest gap between its share price and the brokerage’s target.

Cipla is another preferred pick, with growth expected from its businesses in India and the United States.

Divi’s Laboratories and Anthem Biosciences work in drug development and manufacturing services.

JPMorgan likes both, but its targets suggest little or no share-price upside at current levels.

The companies have different possible growth drivers, such as new products, project work and business integration.

These are the brokerage’s estimates, not guarantees of future performance.